United StatesLegal Representation for Personal Care & Beauty in United States
Taevas Global provides dedicated legal representation so Personal Care & Beauty manufacturers can navigate FDA requirements, labeling mandates, and market entry obligations in the United States with confidence. We act as your on-the-ground legal anchor, r
Six Pillars of United States Personal Care & Beauty Intelligence
Our legal representation framework covers every dimension a Personal Care & Beauty manufacturer needs to enter and sustain operations in the United States market.
FDA Regulatory Compliance
We guide Personal Care & Beauty companies through the Federal Food, Drug, and Cosmetic Act requirements enforced by FDA CFSAN. Our team ensures your products meet ingredient safety standards, prohibited substance lists, and Good Manufacturing Practice expectations before your first shipment crosses the border.
From Brief to Board-Ready Intelligence
Our four-step engagement transforms your market entry intent into a legally sound, fully documented compliance posture ready for FDA scrutiny and retail partner requirements.
Discovery and Scope Definition
We begin with a structured intake session to understand your product portfolio, target distribution channels, and current regulatory status. This allows us to define the precise legal representation scope and identify any immediate compliance gaps that must be addressed before market entry.
During discovery we collect your existing Safety Data Sheets, ingredient lists, current country-of-origin labeling, and any prior FDA correspondence. We also identify whether your products may be classified as cosmetics, OTC drugs, or combination products under United States law, since this classification drives the entire regulatory pathway. A written scope document is issued within 48 hours of the intake session.
United States Personal Care & Beauty Market at a Glance
MoCRA Reshapes the Regulatory Landscape
The Modernization of Cosmetics Regulation Act of 2022 is the most significant overhaul of United States cosmetics law in over 80 years. It mandates facility registration, product listing, Good Manufacturing Practice compliance, and serious adverse event reporting for all cosmetic brands selling in the United States, including foreign manufacturers. Companies that fail to register face import holds and market withdrawal risk.
FDA Enforcement Is Intensifying
FDA CFSAN has increased its cosmetics enforcement activity following MoCRA enactment, issuing warning letters related to drug-cosmetic misbranding, undisclosed ingredients, and unsubstantiated claims. Foreign manufacturers without a United States legal representative are particularly exposed because FDA has no direct point of contact for compliance communications.
Clean Beauty Drives Retailer Compliance Demands
Major United States beauty retailers including Sephora, Ulta, and Target have implemented their own restricted ingredient lists and supplier compliance programs that go beyond FDA minimums. Personal Care & Beauty manufacturers must navigate both federal regulatory requirements and retailer-specific standards to secure and maintain shelf placement in the United States market.
State Regulation Adds Complexity
California's Safe Cosmetics Act requires manufacturers to report products containing chemicals on the state's hazard list to the California Department of Public Health, creating a parallel compliance obligation alongside federal FDA requirements. With California representing the largest single state beauty market in the United States, non-compliance carries significant commercial risk.
Everything in Your Report
Every Legal Representation engagement for Personal Care & Beauty in the United States produces a complete set of compliance documents, registrations, and strategic guidance materials your team can act on immediately.
Regulatory Gap Assessment Report
A prioritized written analysis of every FDA and state-level compliance gap in your current product portfolio, with recommended corrective actions and timelines.
MoCRA Facility Registration and Product Listings
Prepared and submitted registration and product listing files for FDA Cosmetics Direct, covering all applicable products and manufacturing facilities.
Ingredient Compliance Review
A product-by-product review of formulations against FDA prohibited and restricted ingredient lists and applicable state hazard inventories.
Drug vs. Cosmetic Classification Memo
A written legal opinion classifying each product as a cosmetic, OTC drug, or combination product under the FD&C Act, with supporting regulatory citations.
United States Compliant Label Briefs
Artwork-ready label briefs incorporating INCI ingredient declarations, net quantity statements, required warnings, and compliant claim language for each product.
California Safe Cosmetics Act Filing
Preparation and submission of required reports to the California Department of Public Health for products containing reportable ingredients.
Serious Adverse Event Reporting Protocol
A customized internal procedure for capturing, escalating, and reporting serious adverse events to FDA within MoCRA's mandatory 15-business-day reporting window.
Ongoing Legal Representative Retainer
Taevas Global acts as your named United States legal representative for FDA correspondence, annual registration renewals, and proactive regulatory monitoring.
Built for These Situations
Foreign Manufacturer Entering the United States for the First Time
Your Personal Care & Beauty brand has proven success in your home market and is ready to expand to the United States, but you have no existing FDA registrations, no United States legal entity, and no familiarity with MoCRA or FTC requirements. Every shipment without proper representation risks detention at the port of entry.
After Legal Representation, Most Clients Move To
Common Questions
Ready to Map Your United States Opportunity?
Let Taevas Global be your legal anchor in the United States market. Our team of regulatory and legal specialists will get your Personal Care & Beauty products registered, compliant, and shelf-ready faster than any other route.